The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-07-04. Anything still debated is marked as such rather than presented as settled.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
Ghana, officially the Republic of Ghana, is a country in West Africa. It is situated with the Gulf of Guinea and the Atlantic Ocean to the south, and shares borders with Ivory Coast to the west, Burkina Faso to the north, and Togo to the east. Ghana covers an area of 239,567 km2 (92,497 sq mi), spanning various ecologies, from coastal savannas to tropical rainforests. With over 35 million inhabitants, Ghana is the thirteenth-most populous country in Africa, and the second-most populous country in West Africa. The capital and most populous city is Accra. The earliest kingdoms to emerge in Ghana were Bonoman in the south and the Kingdom of Dagbon in the north, with Bonoman existing in the area during the 11th century. The Asante Empire and other Akan kingdoms in the south emerged over the centuries. Beginning in the 15th century, the Portuguese Empire, followed by other European powers, contested the area for trading rights, until the British ultimately established control of the coast by the 19th century. Following more than a century of colonial resistance, the later borders of the country took shape, encompassing four separate British colonial territories: Gold Coast, Ashanti, the Northern Territories, and British Togoland. These were unified as an independent dominion within the Commonwealth of Nations. On 6 March 1957, Ghana became the first colony in Sub-Saharan Africa to achieve sovereignty. Under President Kwame Nkrumah, it became influential in decolonisation efforts and the Pan-African movement.
The fundamental function of platelets is to clump together to stop acute bleeding. This process is complex, as more than 193 proteins and 301 interactions are involved in platelet dynamics. Despite much overlap, platelet function can be modeled in three steps:
After the deaths of three successive elderly Soviet leaders since 1982, the Soviet Politburo elected Gorbachev Communist Party General Secretary in March 1985, marking the rise of a new generation of leadership. Under Gorbachev, relatively young reform-oriented technocrats, who had begun their careers in the heyday of "de-Stalinization" under reformist leader Nikita Khrushchev, rapidly consolidated power, providing new momentum for political and economic liberalization, and the impetus for cultivating warmer relations via glasnost and trade with the West. Historian Sheila Fitzpatrick wrote that Gorbachev looked on these reforms "through the prism of the Thaw, as a revitalization of socialism rather than an abandonment of it."
In Italian, they are called pinoli (in the US, they are often called pignoli, but in Italy, pignolo is actually a word far more commonly used to describe a fussy, overly fastidious or extremely meticulous person) and are an essential component of Italian pesto sauce; the upsurge in the popularity of this sauce since the 1990s has increased the visibility of the nut in America, primarily on the West Coast. Torta della nonna (literally "granny's cake") is a generic Italian dish name that in most families indicates an old family recipe for any cake but often is used for a tart or a pie filled with custard, topped with pine nuts and optionally dusted with icing sugar. Pignoli cookies, an Italian American specialty confection (in Italy, these would be called biscotti ai pinoli), are made of almond flour formed into a dough similar to that of a macaroon and then topped with pine nuts. In the Catalan-speaking regions of Spain, a sweet called panellets is made of small marzipan balls covered with pine nuts, painted with egg, and lightly cooked. Pine nuts are also featured in the salade landaise of southwestern France. Nevada, or Great Basin, pine nut has a sweet fruity flavor and is promoted for its large size, sweet flavor, and ease of peeling.
Sources: en.wikipedia.org
In structural biology, a protein subunit is a polypeptide chain or single protein molecule that assembles (or "coassembles") with others to form a protein complex. Large assemblies of proteins such as viruses often use a small number of types of protein subunits as building blocks. A subunit is often named with a Greek or Roman letter, and the numbers of this type of subunit in a protein is indicated by a subscript. For example, ATP synthase has a type of subunit called α. Three of these are present in the ATP synthase molecule, leading to the designation α3. Larger groups of subunits can also be specified, like α3β3-hexamer and c-ring. Naturally occurring proteins that have a relatively small number of subunits are referred to as oligomeric. For example, hemoglobin is a symmetrical arrangement of two identical α-globin subunits and two identical β-globin subunits. Longer multimeric proteins such as microtubules and other cytoskeleton proteins may consist of very large numbers of subunits. For example, dynein is a multimeric protein complex involving two heavy chains (DHCs), two intermediate chains (ICs), two light-intermediate chains (LICs) and several light chains (LCs). The subunits of a protein complex may be identical, homologous or totally dissimilar and dedicated to disparate tasks. In some protein assemblies, one subunit may be a "catalytic subunit" that enzymatically catalyzes a reaction, whereas a "regulatory subunit" will facilitate or inhibit the activity.
"The Federal Power Commission, Job Bias, and NAACP v. FPC." Akron Law Review, vol. 10, no. 556 (January 1, 1977). "Assumption of the Risk, Comparative Fault and Strict Liability After Rozell." (47 Louisiana Law Review, vol. 57, no. 791 (January 1, 1987). "A Primer on the Louisiana Products Liability Act." Louisiana Law Review, vol. 49, no. 565 (January 1, 1989). The Dimension of Time in the Louisiana Products Liability Act (42 Louisiana Bar Journal (January 1, 1994) "Role of the Consumer Expectation Test Under Louisiana's Products Liability Tort Doctrine." Tulane Law Review, vol. 69, no. 1 (1994-1995), pp. 117–164. Louisiana State Constitutional Law. LSU Publications Institute (January 1, 2012) Kennedy, John (October 7, 2025). How to Test Negative for Stupid: And Why Washington Never Will. Broadside Books. ISBN 978-0063428164.
=== Development after independence === Madras State, the precursor to the present-day state of Tamil Nadu, was created after India became a republic on 26 January 1950. It consisted of present-day Tamil Nadu and parts of present-day Andhra Pradesh, Karnataka, and Kerala. The first legislature of the Madras State to be elected on the basis of universal suffrage was constituted on 1 March 1952, after the general elections held in January 1952. The state was split up along linguistic lines in 1953, carving out Andhra State. Under the States Reorganisation Act, 1956, the states of Kerala and Mysore State were carved out of Madras State. Under the Andhra Pradesh and Madras Alteration of Boundaries Act, 1959, with effect from 1 April 1960, Tiruttani taluk and Pallipattu sub-taluk of Chittoor district of Andhra Pradesh were transferred to Madras in exchange for territories from the Chingelput and Salem districts.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.